Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
2.860
-0.340 (-10.63%)
At close: Mar 6, 2026, 4:00 PM EST
2.870
+0.010 (0.35%)
After-hours: Mar 6, 2026, 7:58 PM EST
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $66.48 million as of March 6, 2026. Its market cap has decreased by -56.53% in one year.
Market Cap
66.48M
Enterprise Value
49.55M
1-Year Change
-56.53%
Ranking
Category
Stock Price
$2.86
Market Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has decreased from $152.13M to $66.48M, a decrease of -56.30%. That is a compound annual growth rate of -41.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 66.48M | -53.27% |
| Dec 31, 2025 | 142.25M | -8.50% |
| Dec 31, 2024 | 155.47M | 2.20% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XBiotech | 71.19M |
| Impact BioMedical | 70.35M |
| Cingulate | 66.99M |
| MediciNova | 66.94M |
| Annovis Bio | 65.99M |
| InflaRx | 65.71M |
| Q32 Bio | 65.66M |
| TScan Therapeutics | 63.56M |